Device Elw

Flexitime Xtreme 2 Correct Flow 12 PC

Payments companies reported to CMS as associated with Flexitime Xtreme 2 Correct Flow 12 PC. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$737associated payments (2023-2025)

11clinicians with associated payments

1company reporting

By year

2025 $737

Payments reported as associated with Flexitime Xtreme 2 Correct Flow 12 PC, per program year, as reported to CMS.

Who makes it

Kulzer, LLC $737 associated with Flexitime Xtreme 2 Correct Flow 12 PC (2023-2025)

Specialties most often involved

Dentist $390

General Practice (Dentist) $275

Advanced Practice Dental Therapist $71.45

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Flexitime Xtreme 2 Correct Flow 12 PC

These are the largest totals companies reported as associated with Flexitime Xtreme 2 Correct Flow 12 PC. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Seok Kim	New York, NY	Dentist	$143.40
Reem Shafi	Aurora, IL	General Practice (Dentist)	$128.33
James Haag	Madisonville, KY	Dentist	$87.68
Kathryn Taylor	Madisonville, KY	Dentist	$87.68
Betty Papanicolaou	Norridge, IL	Dentist	$71.45
Delis Ogando	Jackson, MI	Advanced Practice Dental Therapist	$71.45
Bozena Piekarz	Brooklyn, NY	General Practice (Dentist)	$58.39
Michael Siegel	Cedar Knolls, NJ	General Practice (Dentist)	$22.38
Michael Butkiewicz	Chicago, IL	General Practice (Dentist)	$22.30
Jeffrey Wittmus	Chicago, IL	General Practice (Dentist)	$22.23

Prescribed Flexitime Xtreme 2 Correct Flow 12 PC?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.